PTX 2.56% 4.0¢ prescient therapeutics limited

I had a re-read of the abstract for PTX-100 at the American...

  1. 96 Posts.
    lightbulb Created with Sketch. 50
    I had a re-read of the abstract for PTX-100 at the American Society of Hematology (ASH). I previously skipped over who was listed as the authors (Terrence Chew is the only PTX employee) and that H. Miles Prince from the Peter Mac is the presenting author.

    PTX-100 Authors
    Terrence Chew from Prescient Therapeutics
    Costas K. Yannakou from Epworth HealthCare, Melbourne, VIC
    Vinod Ganju from Peninsula Oncology Centre Consulting Suite, Frankston, VIC, AUS
    Steven Grant from Massey Cancer Center, Virginia Commonwealth University, Richmond, VA
    Said Sebti from Moffitt Cancer Center, Tampa
    H. Miles Prince from Peter MacCallum Cancer Inst., East Melbourne, VIC, AUS

    Of interest, H. Miles Prince is an author of 6 abstract at the ASH.
    https://hotcopper.com.au/data/attachments/5718/5718906-2caca2b1dee45b97c0740aa2ed85505b.jpg

 
watchlist Created with Sketch. Add PTX (ASX) to my watchlist
(20min delay)
Last
4.0¢
Change
0.001(2.56%)
Mkt cap ! $32.21M
Open High Low Value Volume
4.0¢ 4.1¢ 3.9¢ $18.21K 455.2K

Buyers (Bids)

No. Vol. Price($)
2 95694 4.0¢
 

Sellers (Offers)

Price($) Vol. No.
4.1¢ 622328 4
View Market Depth
Last trade - 16.10pm 20/06/2024 (20 minute delay) ?
PTX (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.